Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Baltimore company designing rheumatoid arthritis drug gets OK from FDA to start testing on patients

Summary by Ground News
About 1.5 million Americans suffer from rheumatoid arthritis, a chronic disease. Drugs such as Humira and Enbrel block a molecule called tumor necrosis factor alpha. MyMD-1 can be taken as a tablet, rather than injection or infusion, and its molecules are small.

1 Articles

The Baltimore SunThe Baltimore Sun
Center

Baltimore company designing rheumatoid arthritis drug gets OK from FDA to start testing on patients

Researchers at MyMD, a Baltimore-based pharmaceutical company, think they’ve developed a new drug to treat rheumatoid arthritis that is safer than others on the market.

·Baltimore, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Baltimore Sun broke the news in Baltimore, United States on Monday, October 2, 2023.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Pharma icon

Pharma

Annapolis icon

Annapolis

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal